| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | Brosius Mark EVP & Chief Mfg and Supply Cha | Sale | -48 | -3.30%1,406 | $413.19 | $19,833 | View SEC filing | |
| 2026-06-10 | Brosius Mark EVP & Chief Mfg and Supply Cha | Sale | -69 | -4.53%1,454 | $421.80 | $29,104 | View SEC filing | |
| 2026-06-10 | LOEB GARY EVP & Chief Legal and Complian | Sale | -400 | -6.54%5,720 | $424.14 | $169,656 | View SEC filing | |
| 2026-06-02 | Jeddi Iman SVP & GM da Vinci Platforms & | Sale | -5,625 | -46.53%6,463 | $420.55 | $2,365,594 | View SEC filing | |
| 2026-05-22 | Brosius Mark EVP & Chief Mfg and Supply Cha | Sale | -36 | -2.31%1,523 | $442.92 | $15,945 | View SEC filing | |
| 2026-05-20 | Brosius Mark EVP & Chief Mfg and Supply Cha | Sale | -54 | -3.35%1,559 | $434.52 | $23,464 | View SEC filing | |
| 2026-05-11 | LOEB GARY EVP & Chief Legal and Complian | Sale | -400 | -6.13%6,120 | $446.95 | $178,780 | View SEC filing | |
| 2026-04-28 | Ladd Amy L Director | Sale | -619 | -83.76%120 | $471.55 | $291,887 | View SEC filing | |
| 2026-03-11 | Curet Myriam EVP & Chief Medical Officer | Sale | -105 | -100.00%0 | $493.95 | $51,865 | View SEC filing | |
| 2026-03-10 | Brosius Mark SVP & Chief Mfg and Supply Cha | Sale | -1,293 | -44.49%1,613 | $487.61 | $630,475 | View SEC filing | |
| 2026-03-05 | Brosius Mark SVP & Chief Mfg and Supply Cha | Sale | -3,658 | -55.73%2,906 | $496.19 | $1,815,062 | View SEC filing | |
| 2026-03-03 | Widman Fredrik VP Corporate Controller | Sale | -367 | -11.40%1,026 | $495.68 | $181,915 | View SEC filing | |
| 2026-03-03 | Curet Myriam EVP & Chief Medical Officer | Sale | -4,853 | -92.23%409 | $487.32 | $2,364,961 | View SEC filing | |
| 2026-03-02 | Curet Myriam EVP & Chief Medical Officer | Sale | -2,345 | -85.15%409 | $499.71 | $1,171,820 | View SEC filing | |
| 2026-02-27 | WADORS PATRICIA L SVP Chief Human Resources Offi | Sale | -220 | -100.00%0 | $499.71 | $109,936 | View SEC filing | |
| 2026-02-11 | Widman Fredrik VP Corporate Controller | Sale | -133 | -16.77%660 | $494.96 | $65,830 | View SEC filing | |
| 2026-02-11 | Curet Myriam EVP & Chief Medical Officer | Sale | -526 | -56.26%409 | $494.90 | $260,316 | View SEC filing | |
| 2026-01-30 | Curet Myriam EVP & Chief Medical Officer | Sale | -126 | -100.00%0 | $520.02 | $65,523 | View SEC filing | |
| 2026-01-28 | Curet Myriam EVP & Chief Medical Officer | Sale | -230 | -100.00%0 | $532.61 | $122,500 | View SEC filing | |
| 2026-01-28 | GUTHART GARY S Director | Sale | -27,300 | -43.73%35,134 | $530.24 | $14,475,672 | View SEC filing | |
| 2025-12-17 | Brosius Mark See Remarks | Sale | -464 | -77.98%131 | $548.49 | $254,499 | View SEC filing | |
| 2025-12-17 | Brosius Mark See Remarks | Sale | -312 | -34.40%595 | $547.36 | $170,776 | View SEC filing | |
| 2025-12-15 | Brosius Mark SVP & Chief Mfg and Supply Cha | Sale | -4,964 | -91.81%443 | $547.47 | $2,717,619 | View SEC filing | |
| 2025-12-10 | Curet Myriam EVP & Chief Medical Officer | Sale | -104 | -100.00%0 | $559.90 | $58,230 | View SEC filing | |
| 2025-12-02 | Curet Myriam EVP & Chief Medical Officer | Sale | -125 | -100.00%0 | $568.99 | $71,124 | View SEC filing |
1-25 of 766
